The Scientist - Home

A study in people fails to detect differences in the brain’s response to fear or anxiety, long thought to be controlled by different neural circuits.

A small study shows artificial intelligence can pick out individuals with coronavirus infections, but ophthalmologists and AI experts say the approach is far from proven to be capable of distinguishing infections with SARS-CoV-2 from other ills.

Other recipients of the award for laugh-worthy achievements experimented with alligators on helium and vibrating worms.

Several organizations suggest that a case against a University of Kansas professor is the latest example of the US government targeting researchers for their ethnicity.

Eli Lilly reports a 72 percent reduction in hospitalization risk among patients who received its monoclonal antibody compared to those who received a placebo.

The mountain is home to two historic telescopes and many other scientific instruments, along with a billion dollars’ worth of broadcast transmission towers.

Researchers are trying to make sense of immune systems gone haywire and develop biomarkers to predict who will become the sickest from a coronavirus infection.

Student workers have cited a lack of transparency and a failure to implement rapid and widespread testing among their many concerns regarding the school’s response to the pandemic.

The technique is designed for breeding genetically superior farm animals, but may have additional conservation and medical applications.

A randomized controlled trial on the use of convalescent plasma therapy to treat coronavirus infections—the first in the world to be completed—yields disappointing results, but some doctors are not discouraged.

Gamma delta T cells in the meninges of the brain release a cell signaling molecule that does more than protect mice from microbial pathogens.

Images of the players’ hearts showed signs of inflammation consistent with myocarditis, a rare but potentially fatal condition.